 |
| (Photo Source: Searle Company Ltd) |
Searle Company Ltd launches the first generic remedial injection treatment for COVID-19 patients in Pakistan. Serial Company Limited has delivered the first batch of Remedesivir injections for COVID-19 hospitalized patients.
Searle thanked Bexmco's management and the Pakistani authorities for their generosity and timely assistance. Serial proudly upholds its socially responsible values in which it is encouraged to play its part in fighting the crisis by playing its part in COVID-19 epidemic awareness, prevention, detection, and management. We will offer its services.
Serial Company Limited successfully launched Remedicure Injection, under the exclusive license and marketing agreement of Coiled 19 Drug Remediver. Serial Pakistan has recently entered into an agreement with Bexmco Pharmaceuticals of Bangladesh to market Coxedia-19 Drug Remedies.
This friendly cooperation will provide fast delivery of manufactured products at reasonable prices and will also help Pakistani healthcare workers to treat patients with COVID 19 hospitalized without any delay.
Initially, the aim of the serial is to import Remedesivir in a ready-to-use form to meet the immediate needs of the country.
In addition, the serial also intends to donate large quantities of remediation to the Government of Pakistan, which is actively fighting the epidemic.
The world's pharmaceutical companies claim to have invented a vaccine for COVID-19, as well as a cure. Gilead stunned the world with his constructive efforts against the virus.
Basically, Remedesivir has been tested and found to have the potential to reduce the time required for the recovery of COVID-19 patients.
RemediesDavire, in fact, was designed to help treat hepatitis C patients. Surprisingly, this substance has shown its ability to perform multitasking as Remedesivir can help treat many other viruses.
It battled three major diseases a few years ago that wiped out the world's largest population, Severe Acute Respiratory Syndrome (SARS), Middle Eastern Respiratory Syndrome (MER), and the Ebola virus.
Although it is not accepted as a completely effective treatment for diseases, it has somehow worked in past crises.
This injection is now available in the market. According to the report, this is a course consisting of 11 courses, a vaccine costs Rs 20,000 while the total cost of the entire course is Rs 220,000.
0 Comments